{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:56:56Z","timestamp":1792717016075,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jaci.2024.05.026","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T20:07:40Z","timestamp":1717790860000},"page":"996-1007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Leukotriene receptor antagonists as add-on therapy to antihistamines for urticaria: Systematic review and meta-analysis of randomized clinical trials"],"prefix":"10.1016","volume":"154","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6699-3090","authenticated-orcid":false,"given":"Daniel G.","family":"Rayner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandro W.L.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiajing","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon H.","family":"Guyatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Oykhman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Moellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Ben-Shoshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane R.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Waserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer K.","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric T.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel N.","family":"Asiniwasis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily F.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Runyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn P.","family":"Trayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Eftekhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna D.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonya","family":"Winders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarbjit S.","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8269-4496","authenticated-orcid":false,"given":"Derek K.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2024.05.026_bib1","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.jaci.2014.02.036","article-title":"The diagnosis and management of acute and chronic urticaria: 2014 update","volume":"133","author":"Bernstein","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.026_bib2","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3796","article-title":"Global epidemiology of urticaria: increasing burden among children, females and low-income regions","volume":"101","author":"Peck","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2024.05.026_bib3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/all.14037","article-title":"Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis","volume":"75","author":"Fricke","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.05.026_bib4","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.jaip.2020.03.030","article-title":"Urticaria and angioedema across the ages","volume":"8","author":"Saini","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.05.026_bib5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/bjd.19561","article-title":"The global burden of chronic urticaria for the patient and society","volume":"184","author":"Gon\u00e7alo","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2024.05.026_bib6","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1056\/NEJMra2120166","article-title":"Chronic urticaria","volume":"387","author":"Lang","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2024.05.026_bib7","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jaci.2020.07.007","article-title":"Rhinitis 2020: a practice parameter update","volume":"146","author":"Dykewicz","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.026_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1164\/rccm.202109-2205PP","article-title":"Global Initiative for Asthma Strategy, 2021: executive summary and rationale for key changes","volume":"205","author":"Reddel","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.05.026_bib9","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jaci.2017.03.050","article-title":"Allergic rhinitis and its impact on asthma (ARIA) guidelines\u20142016 revision","volume":"140","author":"Bro\u017cek","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.026_bib10","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jaci.2023.08.029","article-title":"Systemic treatments for atopic dermatitis (eczema): systematic review and network meta-analysis of randomized trials","volume":"152","author":"Chu","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.026_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1398-9995.2005.00658.x","article-title":"Increased levels of urinary leukotriene E4 in children with severe atopic eczema\/dermatitis syndrome","volume":"60","author":"\u00d8ymar","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.05.026_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jaci.2009.03.012","article-title":"Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions","volume":"124","author":"Arias","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.026_bib15","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/all.15090","article-title":"The international EAACI\/GA2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria","volume":"77","author":"Zuberbier","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.05.026_bib17","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1016\/j.jaip.2022.08.033","article-title":"Boxed warnings and off-label use of allergy medications: risks, benefits, and shared decision making","volume":"10","author":"Greiwe","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.05.026_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1710-1492-10-24","article-title":"Leukotriene receptor antagonists for chronic urticaria: a systematic review","volume":"10","author":"de Silva","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.026_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/JAA.S3236","article-title":"Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review","volume":"2","author":"Di Lorenzo","year":"2008","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jaci.2024.05.026_bib20","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2019"},{"issue":"7650","key":"10.1016\/j.jaci.2024.05.026_bib21","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jaci.2024.05.026_bib22","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/j.jaip.2021.09.035","article-title":"Translating evidence to optimize patient care using GRADE","volume":"9","author":"Chu","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.05.026_bib23","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jaci.2023.08.030","article-title":"Topical treatments for atopic dermatitis (eczema): systematic review and network meta-analysis of randomized trials","volume":"152","author":"Chu","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.026_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S2352-4642(22)00283-8","article-title":"Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis","volume":"7","author":"Devasenapathy","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jaci.2024.05.026_bib25","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/j.jaip.2022.06.044","article-title":"Dietary elimination for the treatment of atopic dermatitis: a systematic review and meta-analysis","volume":"10","author":"Oykhman","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.05.026_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2024.04.016","article-title":"Efficacy and safety of systemic corticosteroids for urticaria: a systematic review and meta-analysis of randomized clinical trials","author":"Chu","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.05.026_bib27","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jaci.2024.05.026_bib28","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jaci.2024.05.026_bib29","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence\u2014publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaci.2024.05.026_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaci.2024.05.026_bib31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jrsm.1429","article-title":"Optimally estimating the sample standard deviation from the five-number summary","volume":"11","author":"Shi","year":"2020","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.jaci.2024.05.026_bib32","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jaci.2021.09.009","article-title":"Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: a systematic review and network meta-analysis","volume":"149","author":"Oykhman","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.026_bib33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jclinepi.2012.08.001","article-title":"GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaci.2024.05.026_bib34","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/jrsm.46","article-title":"Pooling health-related quality of life outcomes in meta-analysis\u2014a tutorial and review of methods for enhancing interpretability","volume":"2","author":"Thorlund","year":"2011","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.jaci.2024.05.026_bib35","doi-asserted-by":"crossref","first-page":"E901","DOI":"10.1503\/cmaj.200077","article-title":"Development of the Instrument to assess the credibility of effect modification analyses (ICEMAN) in randomized controlled trials and meta-analyses","volume":"192","author":"Schandelmaier","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.jaci.2024.05.026_bib36","article-title":"Efficacy of awake prone positioning in patients with covid-19 related hypoxemic respiratory failure: systematic review and meta-analysis of randomized trials","volume":"379","author":"Weatherald","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.jaci.2024.05.026_bib37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1164\/rccm.202006-2381CP","article-title":"Using Bayesian methods to augment the interpretation of critical care trials. an overview of theory and example reanalysis of the alveolar recruitment for acute respiratory distress syndrome trial","volume":"203","author":"Zampieri","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.05.026_bib38","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/sim.6381","article-title":"Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis","volume":"34","author":"Turner","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.jaci.2024.05.026_bib39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2021.03.026","article-title":"GRADE guidelines 32: GRADE offers guidance on choosing targets of GRADE certainty of evidence ratings","volume":"137","author":"Zeng","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaci.2024.05.026_bib40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.anai.2011.09.008","article-title":"Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria","volume":"108","author":"Mathias","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.05.026_bib41","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1016\/j.jaip.2022.06.017","article-title":"Trustworthy patient-centered guidelines: insights from atopic dermatitis and a proposal for the future","volume":"10","author":"Agarwal","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.05.026_bib42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaci.2003.10.002","article-title":"The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results","volume":"113","author":"Bagenstose","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.026_bib43","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaci.2004.06.018","article-title":"Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria","volume":"114","author":"Di Lorenzo","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.026_bib44","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1067\/mai.2002.126676","article-title":"The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study","volume":"110","author":"Erbagci","year":"2002","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl\u00a01","key":"10.1016\/j.jaci.2024.05.026_bib45","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/S0954-6111(11)70018-X","article-title":"Add-on montelukast in antihistamine-resistant chronic idiopathic urticaria","volume":"105","author":"Kosnik","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.jaci.2024.05.026_bib46","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1067\/mai.2003.1559","article-title":"Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria","volume":"112","author":"Nettis","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.05.026_bib47","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1365-2222.2004.02019.x","article-title":"Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study","volume":"34","author":"Nettis","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2024.05.026_bib48","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1365-2133.2006.07533.x","article-title":"Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double-blind, placebo-controlled study","volume":"155","author":"Nettis","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2024.05.026_bib49","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4103\/ijdvl.IJDVL_551_16","article-title":"Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: a double-blind, randomized, controlled trial","volume":"83","author":"Sarkar","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaci.2024.05.026_bib50","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/09546630802607495","article-title":"Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria","volume":"20","author":"Wan","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaci.2024.05.026_bib51","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/09546634.2013.849791","article-title":"Efficacy of leukotriene receptor antagonist with anti-H1 receptor antagonist plus anti-H2 receptor antagonist for treatment of refractory chronic idiopathic urticaria","volume":"25","author":"Wan","year":"2014","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaci.2024.05.026_bib52","first-page":"32","article-title":"[Effect of montelukast sodium tablets combined with levocetirizine hydrochloride tablets in the treatment of patients with chronic urticaria]","volume":"31","author":"Liu","year":"2019","journal-title":"Chin Minkang Med"},{"key":"10.1016\/j.jaci.2024.05.026_bib53","first-page":"227","article-title":"[Efficacy evaluation of desloratadine combined with montelukast sodium in the treatment of chronic urticaria]","volume":"4","author":"Liu","year":"2015","journal-title":"Chin J Leprosy Skin Dis"},{"key":"10.1016\/j.jaci.2024.05.026_bib54","first-page":"62","article-title":"[Clinical effect of montelukast sodium tablets combined with levocetirizine hydrochloride tablets in the treatment of chronic urticaria]","volume":"7","author":"Zhou","year":"2022","journal-title":"Clin Med Res Pract"},{"key":"10.1016\/j.jaci.2024.05.026_bib55","first-page":"94","article-title":"[Efficacy of montelukast combined with levocetirizine in the treatment of chronic urticaria]","volume":"11","author":"Zhou","year":"2018","journal-title":"J Clin Rational Drug Use"},{"key":"10.1016\/j.jaci.2024.05.026_bib56","series-title":"Proceedings of the East Asian Allergy Forum of the Chinese Medical Association 2013 National Allergy Academic Conference","first-page":"161","article-title":"[Observation on therapeutic effect of montelukast in treating 124 cases of chronic urticaria]","author":"An","year":"2013"},{"key":"10.1016\/j.jaci.2024.05.026_bib57","first-page":"1223","article-title":"[Observation on the curative effect of levocetirizine combined with montelukast in the treatment of chronic idiopathic urticaria in children]","volume":"42","author":"Liao","year":"2017","journal-title":"J Bengbu Med College"},{"key":"10.1016\/j.jaci.2024.05.026_bib58","first-page":"74","article-title":"[Observation on the effect of levocetirizine hydrochloride oral solution combined with montelukast sodium chewable tablets in the treatment of chronic urticaria in children]","volume":"38","author":"Zhang","year":"2022","journal-title":"Chin Commun Physician"},{"key":"10.1016\/j.jaci.2024.05.026_bib59","first-page":"240","article-title":"[Efficacy evaluation of desloratadine citrate tablets combined with montelukast sodium tablets in the treatment of chronic urticaria]","volume":"29","author":"Zhang","year":"2016","journal-title":"Medical Information (Xi\u2019an)"},{"issue":"suppl\u00a02","key":"10.1016\/j.jaci.2024.05.026_bib60","first-page":"36","article-title":"[Clinical effect of combined application of ebastine and montelukast sodium in the treatment of patients with chronic urticaria]","volume":"32","author":"Zhang","year":"2017","journal-title":"Chin Med Equip"},{"key":"10.1016\/j.jaci.2024.05.026_bib61","first-page":"233","article-title":"[Value experience of desloratadine citrate combined with montelukast in the treatment of chronic urticaria]","volume":"21","author":"Wei","year":"2021","journal-title":"Health Must Read"},{"key":"10.1016\/j.jaci.2024.05.026_bib62","first-page":"226","article-title":"[Effect of montelukast sodium combined with levocetirizine on serum IgE, IL-18 and SVCAM-1 levels in children with chronic idiopathic urticaria]","volume":"42","author":"Li","year":"2021","journal-title":"Dermatol STDs"},{"key":"10.1016\/j.jaci.2024.05.026_bib63","first-page":"38","article-title":"[Clinical study on the combined treatment of desloratadine and montelukast sodium in chronic urticaria]","volume":"6","author":"Du","year":"2016","journal-title":"Chin Med Sci"},{"key":"10.1016\/j.jaci.2024.05.026_bib64","first-page":"109","article-title":"[Therapeutic observation and mechanism analysis of cetirizine hydrochloride combined with montelukast sodium in the treatment of chronic urticaria]","volume":"38","author":"Yang","year":"2019","journal-title":"Chin Foreign Med"},{"key":"10.1016\/j.jaci.2024.05.026_bib65","first-page":"719","article-title":"[Clinical effect of desloratadine citrate combined with montelukast in the treatment of chronic urticaria]","volume":"41","author":"Wang","year":"2019","journal-title":"Dermatol STDs"},{"key":"10.1016\/j.jaci.2024.05.026_bib66","first-page":"29","article-title":"[Efficacy of montelukast combined with epinastine in the treatment of chronic urticaria]","volume":"36","author":"Yuan","year":"2014","journal-title":"Dermatol STDs"},{"key":"10.1016\/j.jaci.2024.05.026_bib67","first-page":"61","article-title":"[Observation on the curative effect of montelukast sodium combined with loratadine in the treatment of chronic urticaria]","volume":"29","author":"Guo","year":"2013","journal-title":"Chin J Leprosy Skin Dis"},{"key":"10.1016\/j.jaci.2024.05.026_bib68","first-page":"159","article-title":"[Effect analysis of ebastine combined with montelukast sodium in the treatment of chronic urticaria]","volume":"15","author":"Qian","year":"2017","journal-title":"Contemp Med"},{"key":"10.1016\/j.jaci.2024.05.026_bib69","first-page":"21","article-title":"[Observation on curative effect of gradually decreasing loratadine combined with montelukast in the treatment of chronic urticaria]","volume":"11","author":"Han","year":"2013","journal-title":"Chin Med Guide"},{"key":"10.1016\/j.jaci.2024.05.026_bib70","first-page":"4560","article-title":"[Observation on the efficacy of cetirizine, ranitidine combined with montelukast sodium in the treatment of chronic idiopathic urticaria]","volume":"7","author":"Li","year":"2014","journal-title":"Chin Health Nutr"},{"key":"10.1016\/j.jaci.2024.05.026_bib71","first-page":"1972","article-title":"[Effects of montelukast sodium combined with olopatadine in the treatment of chronic urticaria on patients\u2019 immune function and related inflammatory factors]","volume":"45","author":"Yang","year":"2023","journal-title":"Hebei Med"},{"key":"10.1016\/j.jaci.2024.05.026_bib72","first-page":"16","article-title":"[Observation on the clinical efficacy of terfenadine combined with montelukast sodium in the treatment of urticaria]","volume":"22","author":"Situ","year":"2013","journal-title":"Med Aesthet Cosmetol"},{"key":"10.1016\/j.jaci.2024.05.026_bib73","first-page":"122","article-title":"[Study on the clinical efficacy of montelukast in the treatment of acute urticaria in children]","volume":"28","author":"Tang","year":"2014","journal-title":"Prim Health Care China"},{"key":"10.1016\/j.jaci.2024.05.026_bib74","first-page":"216","article-title":"[Observation on the use of montelukast in the treatment of skin diseases]","volume":"33","author":"Xu","year":"2012","journal-title":"Med Front"},{"key":"10.1016\/j.jaci.2024.05.026_bib75","first-page":"84","article-title":"[Observation and analysis of the clinical efficacy of montelukast in the adjuvant treatment of acute urticaria]","volume":"19","author":"Jin","year":"2012","journal-title":"Chin Contemp Med"},{"key":"10.1016\/j.jaci.2024.05.026_bib76","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1477-7525-3-36","article-title":"Minimal important difference (MID) of the Dermatology Life Quality Index (DLQI): results from patients with chronic idiopathic urticaria","volume":"3","author":"Shikiar","year":"2005","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jaci.2024.05.026_bib77","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.13643","article-title":"Analysis of neuropsychiatric diagnoses after montelukast initiation","volume":"5","author":"Paljarvi","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaci.2024.05.026_bib78","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jclinepi.2023.05.010","article-title":"The development methods of official GRADE articles and requirements for claiming the use of GRADE\u2014a statement by the GRADE guidance group","volume":"159","author":"Sch\u00fcnemann","year":"2023","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaci.2024.05.026_bib79","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jaip.2018.04.026","article-title":"Montelukast reduces symptom severity and frequency in patients with angioedema-predominant chronic spontaneous urticaria","volume":"6","author":"Akenroye","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.05.026_bib80","article-title":"The addition of montelukast for the treatment of chronic idiopathic urticaria","volume":"13","author":"Alkeraye","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jaci.2024.05.026_bib81","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.jclinepi.2004.03.017","article-title":"An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods","volume":"57","author":"Devereaux","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaci.2024.05.026_bib82","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1745-6215-11-32","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"11","author":"Schulz","year":"2010","journal-title":"Trials"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924005712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924005712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T08:06:07Z","timestamp":1728374767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674924005712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0091674924005712"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2024.05.026","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leukotriene receptor antagonists as add-on therapy to antihistamines for urticaria: Systematic review and meta-analysis of randomized clinical trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2024.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}